| Literature DB >> 34904931 |
Gargi Ghosh1, Satyabrata Samui2, Santanu Das3, Vandana Singh4, Doel Pal1, Subhanwita Das1, Jishu Naskar2, Soumya Sinha Roy4, Utpal Basu1.
Abstract
Upregulation of utrophin, the autosomal homologue of dystrophin, can compensate dystrophin deficiency in Duchenne Muscular Dystrophy (DMD) although the therapeutic success is yet to be achieved. The present study has identified Poly (C) binding protein 2 (PCBP2) as a post-transcriptional suppresser for the expression of utrophin-A, the muscle-specific utrophin isoform. This study confirms nuclear retention of utrophin-A mRNA in C2C12 cells, which is mediated by PCBP2. Further investigation demonstrates PCBP2-dependent nuclear retention of follistatin mRNA as well. Its involvement in nuclear retention of mRNA sheds light on a novel function of PCBP2 that makes utrophin-A mRNA less available in cytosol. PCBP2, therefore, may be a target to de-repress utrophin-A expression in DMD.Entities:
Keywords: DMD; PCBP2; follistatin; nuclear retention; utrophin-A
Mesh:
Substances:
Year: 2021 PMID: 34904931 PMCID: PMC8782177 DOI: 10.1080/15476286.2021.2004683
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652